INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice.

David M G HalpinSally WorsleyAfisi S IsmailaKai-Michael BeehDawn MidwinterJanwillem W H KocksElaine IrvingJose Maria Marin TrigoNeil MartinMaggie TabbererNeil G SnowiseChris Compton

Published in: ERJ open research (2021)

In a usual clinical care setting, treatment with once-daily single-inhaler FF/UMEC/VI resulted in significantly more patients gaining health status improvement and greater lung function improvement versus non-ELLIPTA MITT.

Keyphrases

lung function
chronic obstructive pulmonary disease
end stage renal disease
cystic fibrosis
clinical practice
air pollution
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
palliative care
prognostic factors
physical activity
quality improvement
health insurance